MC2 and Almirall clear crucial obstacle to psoriasis treatment in Europe

Danish company MC Therapeutics' psoriasis cream Wynzora has cleared another obstacle on the way to the EU markets.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Almirall starts the year with solid growth
For subscribers
Leo Pharma to collaborate with US biotech company
For subscribers